Cargando…

Renin-Angiotensin-System Inhibitors Are Associated With Lower In-hospital Mortality in COVID-19 Patients Aged 80 and Older

BACKGROUND: Older adults are at higher risk of morbidity and mortality for coronavirus disease 2019 (COVID-19). Renin-angiotensin-system inhibitors (RASi) were found to have a neutral or protective effect against mortality in COVID-19 adult patients. AIMS: We investigated whether this association wa...

Descripción completa

Detalles Bibliográficos
Autores principales:	Spannella, Francesco, Giulietti, Federico, Di Pentima, Chiara, Allevi, Massimiliano, Bordoni, Valentina, Filipponi, Andrea, Falzetti, Sara, Garbuglia, Caterina, Scorcella, Samuele, Giordano, Piero, Sarzani, Riccardo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Cardiovascular Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9247386/ https://www.ncbi.nlm.nih.gov/pubmed/35783862 http://dx.doi.org/10.3389/fcvm.2022.916509

Ejemplares similares

The Identikit of Patient at Risk for Severe COVID-19 and Death: The Dysregulation of Renin-Angiotensin System as the Common Theme
por: Sarzani, Riccardo, et al.
Publicado: (2021)

Antagonizing the renin–angiotensin–aldosterone system in the era of COVID-19
por: Sarzani, Riccardo, et al.
Publicado: (2020)

The Number of Pills, Rather Than the Type of Renin–Angiotensin System Inhibitor, Predicts Ambulatory Blood Pressure Control in Essential Hypertensives on Triple Therapy: A Real-Life Cross-Sectional Study
por: Sarzani, Riccardo, et al.
Publicado: (2021)

Painful and recurring injection site reaction to alirocumab and evolocumab in a young woman with familial hypercholesterolemia and effective therapeutic alternative based on inclisiran: a case report
por: Allevi, Massimiliano, et al.
Publicado: (2023)

Role of Cardiac Natriuretic Peptides in Heart Structure and Function
por: Sarzani, Riccardo, et al.
Publicado: (2022)

Possible harm from glucocorticoid drugs misuse in the early phase of SARS-CoV-2 infection: a narrative review of the evidence
por: Sarzani, Riccardo, et al.
Publicado: (2021)

Role of Cardio-Renal Dysfunction, Inflammation Markers, and Frailty on In-Hospital Mortality in Older COVID-19 Patients: A Cluster Analysis
por: Spannella, Francesco, et al.
Publicado: (2023)

Prevalence and Control of Dyslipidemia in Patients Referred for High Blood Pressure: The Disregarded “Double-Trouble” Lipid Profile in Overweight/Obese
por: Spannella, Francesco, et al.
Publicado: (2019)

Effect of sacubitril/valsartan on renal function: a systematic review and meta‐analysis of randomized controlled trials
por: Spannella, Francesco, et al.
Publicado: (2020)

Plasma Levels of Proprotein Convertase Subtilisin/Kexin Type 9 Are Inversely Associated with N-Terminal Pro B-Type Natriuretic Peptide in Older Men and Women
por: Spannella, Francesco, et al.
Publicado: (2022)

Pharmacological Approach to Smoking Cessation: An Updated Review for Daily Clinical Practice
por: Giulietti, Federico, et al.
Publicado: (2020)

Radiological lung sequelae, functional status and symptoms in older patients 3 and 6 months after hospitalization for COVID-19 pneumonia
por: Di Pentima, Chiara, et al.
Publicado: (2023)

A 95-year-old patient with unexpected coronavirus disease 2019 masked by aspiration pneumonia: a case report
por: Spannella, Francesco, et al.
Publicado: (2020)

Single-pill fixed-dose drug combinations to reduce blood pressure: the right pill for the right patient
por: Sarzani, Riccardo, et al.
Publicado: (2022)

NT-proBNP and Its Correlation with In-Hospital Mortality in the Very Elderly without an Admission Diagnosis of Heart Failure
por: Sarzani, Riccardo, et al.
Publicado: (2016)

Association Between Cardiac Natriuretic Peptides and Lipid Profile: a Systematic Review and Meta-Analysis
por: Spannella, Francesco, et al.
Publicado: (2019)

Renal effects of Sacubitril/Valsartan in heart failure with reduced ejection fraction: a real life 1-year follow-up study
por: Spannella, Francesco, et al.
Publicado: (2019)

Cardiac Natriuretic Peptides, Hypertension and Cardiovascular Risk
por: Sarzani, Riccardo, et al.
Publicado: (2017)

PCSK9 is Expressed in Human Visceral Adipose Tissue and Regulated by Insulin and Cardiac Natriuretic Peptides
por: Bordicchia, Marica, et al.
Publicado: (2019)

COVID and the Renin-Angiotensin System: Are Hypertension or Its Treatments Deleterious?
por: Zores, Florian, et al.
Publicado: (2020)

Prevalence and predictors of subclinical atrial fibrillation in hospitalized older adults
por: Spannella, Francesco, et al.
Publicado: (2021)

Renin-Angiotensin System and Coronavirus Disease 2019: A Narrative Review
por: Mascolo, Annamaria, et al.
Publicado: (2020)

OR04-5 Stimulation of Protein Disulfide Isomerase Activity by Activation of The Renin-Angiotensin System
por: Irizarry, Jose, et al.
Publicado: (2019)

Sex differences in the renin-angiotensin-aldosterone system and its roles in hypertension, cardiovascular, and kidney diseases
por: Nwia, Sarah M., et al.
Publicado: (2023)

OR04-1 Dietary Sodium Intake, the Renin-Angiotensin-Aldosterone System, and the Risk for Incident Kidney Stones
por: Bayomy, Omar, et al.
Publicado: (2019)

Manipulation of components of the renin angiotensin system in renal proximal tubules fails to alter atherosclerosis in hypercholesterolemic mice
por: Kukida, Masayoshi, et al.
Publicado: (2023)

Chronic Kidney Disease Is Characterized by “Double Trouble” Higher Pulse Pressure plus Night-Time Systolic Blood Pressure and More Severe Cardiac Damage
por: Fedecostante, Massimiliano, et al.
Publicado: (2014)

Effects of Statins on Renin–Angiotensin System
por: Kiaie, Nasim, et al.
Publicado: (2021)

SAT-066 Effect Of Interleukin-1-receptor Antagonist On Hemodynamics And Renin-angiotensin-aldosterone System In Obese Individuals
por: Urwyler, Sandrine, et al.
Publicado: (2019)

Lack of Effects of Renin-Angiotensin-Aldosterone System Activity and Beta-Adrenoceptor Pathway Polymorphisms on the Response to Bisoprolol in Hypertension
por: Zeng, Weiwei, et al.
Publicado: (2022)

Outcomes of discontinuing renin-angiotensin system inhibitors: a study protocol for conducting systematic review and meta-analysis
por: Suzuki, Taihei, et al.
Publicado: (2023)

Patients With Obesity-Related Hypertension Treated With Renin-Angiotensin-Aldosterone System Antagonists Exhibit Lower Mortality And Less Severe COVID-19: A Retrospective Study
por: Kamalumpundi, Vijayvardhan, et al.
Publicado: (2021)

SUN-LB94 Impact of the Gut Microbiome and Renin-Angiotensin-Aldosterone System in Hypertensive Patients With Low-Salt Intake
por: Taniguchi, Kouki, et al.
Publicado: (2020)

What’s new in the renin-angiotensin system?: What’s new in the renin-angiotensin system?
por: Smith, A. I., et al.
Publicado: (2004)

SAT-057 Endoplasmic Reticulum Aminopeptidase-1 Is a Novel Regulator of the Renin-Angiotensin-Aldosterone System and Blood Pressure Homeostasis
por: Ranjit, Sanjay
Publicado: (2019)

Vitamin D Deficiency Induces Macrophage Pro-Inflammatory Phenotype via ER Stress-Mediated Activation of Renin-Angiotensin System
por: Bauerle, Kevin Thomas, et al.
Publicado: (2021)

Renin-Angiotensin System and Sex Differences in COVID-19: A Critical Assessment
por: Chappell, Mark C.
Publicado: (2023)

Prospective meta-analysis protocol on randomised trials of renin–angiotensin system inhibitors in patients with COVID-19: an initiative of the International Society of Hypertension
por: Gnanenthiran, Sonali Rukshana, et al.
Publicado: (2021)

Adherence to guidelines for creatinine and potassium monitoring and discontinuation following renin–angiotensin system blockade: a UK general practice-based cohort study
por: Schmidt, Morten, et al.
Publicado: (2017)

Biochemical monitoring after initiation of aldosterone antagonist therapy in users of renin–angiotensin system blockers: a UK primary care cohort study
por: Sinnott, Sarah-Jo, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_t9d3m2ih6e30gncrvep2b2ut4v